This paper is in the following e-collection/theme issue:

Mobile Health (mhealth) (2777) mHealth in a Clinical Setting (582) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1317)

Published on in Vol 24, No 9 (2022): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37445, first published .
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey

Authors of this article:

Esther Chamorro-de-Vega1, 2 Author Orcid Image ;   Rosa Romero-Jiménez2 Author Orcid Image ;   Vicente Escudero-Vilaplana2 Author Orcid Image ;   Arantza Ais-Larisgoitia2 Author Orcid Image ;   María Elena Lobato Matilla2 Author Orcid Image ;   Carlos M González3 Author Orcid Image ;   Luis Menchén4, 5 Author Orcid Image ;   Ofelia Baniandrés6 Author Orcid Image ;   Lucía Ibares-Frias7 Author Orcid Image ;   Carmen Lobo-Rodríguez8 Author Orcid Image ;   Ana Herranz-Alonso2 Author Orcid Image ;   María Sanjurjo2 Author Orcid Image
Article Authors Cited by (3) Tweetations (9) Metrics

Journals

  1. Cobelli N, Cassia F, Zardini A, Kuppelwieser V. Pharmacies providing health services: Attitudes toward eHealth in Italy. Journal of Retailing and Consumer Services 2024;76:103568 View
  2. Ni Z, Zhu L, Li S, Zhang Y, Zhao R. Characteristics and associated factors of health information-seeking behaviour among patients with inflammatory bowel disease in the digital era: a scoping review. BMC Public Health 2024;24(1) View
  3. López Sánchez P, Palanques Pastor T, Ibarra Barrueta O, Ramírez Herráiz E, Casellas Gibert M, Monte Boquet E. Análisis de la situación de la atención farmacéutica a pacientes con enfermedades inflamatorias inmunomediadas antes y después de la pandemia COVID-19. Farmacia Hospitalaria 2024 View